CoChat

PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response.

Open access

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

Posttranslational modifications to the intracellular domain of the EGFR are known to regulate EGFR functions; however, modifications to the extracellular domain and their effects remain relatively unexplored. Here, we determined that methylation at R198 and R200 of the EGFR extracellular domain by protein arginine methyltransferase 1 (PRMT1) enhances binding to EGF and subsequent receptor dimerization and signaling activation. In a mouse orthotopic colorectal cancer xenograft model, expression of a methylation-defective EGFR reduced tumor growth. Moreover, increased EGFR methylation sustained signaling activation and cell proliferation in the presence of the therapeutic EGFR monoclonal antibody cetuximab. In colorectal cancer patients, EGFR methylation level also correlated with a higher recurrence rate after cetuximab treatment and reduced overall survival. Together, these data indicate that R198/R200 methylation of the EGFR plays an important role in regulating EGFR functionality and resistance to cetuximab treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci82826

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Cited by

See all 156

Metadata

Authors
Liao, H.-W., Hsu, J.-M., Xia, W., Wang, H.-L., Wang, Y.-N., Chang, W.-C., Arold, S. T., Chou, C.-K., Tsou, P.-H., Yamaguchi, H., Fang, Y.-F., Lee, H.-J., Lee, H.-H., Tai, S.-K., Yang, M.-H., Morelli, M. P., Sen, M., Ladbury, J. E., Chen, C.-H., Grandis, J. R., Kopetz, S., & Hung, M.-C.
Affiliations
  • The University of Texas MD Anderson Cancer Center (US)
  • China Medical University (TW)
  • Taipei Veterans General Hospital (TW)
  • National Yang Ming University (TW)
  • University of Pittsburgh (US)
  • University of Leeds (GB)
  • Genomics Research Center, Academia Sinica (TW)
Venue
Journal of Clinical Investigation
Published
2015-11-16
Volume
125
Issue
12
Pages
4529-4543
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2176390318
Cited by
155
References
60
Citations by year
2026: 6 · 2025: 13 · 2024: 15 · 2023: 15 · 2022: 12 · 2021: 24 · 2020: 19 · 2019: 16 · 2018: 11 · 2017: 15 · 2016: 8 · 2015: 1
FWCI
5.10
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • King Abdullah University of Science and Technology Repository (King Abdullah University of Science and Technology) (submittedVersion)
Funders
National Cancer Institute (CCSG CA 16672, CA 016672, CA109311, R01CA109311, P01CA099031, P30CA016672, P50CA097190, CA 099031)
Topics
  • Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
Keywords
EGFR, PRMT1, arginine methylation, cetuximab resistance, EGFR signaling, receptor dimerization, colorectal cancer, tumor recurrence, overall survival, monoclonal antibody therapy
MeSH terms
Cetuximab, Animals, Colonic Neoplasms, Female, Humans, Methylation, Mice, Nude, Neoplasm Transplantation, Protein-Arginine N-Methyltransferases, Repressor Proteins, Signal Transduction, Cell Line, Tumor, Mice, Heterografts, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response. https://app.cochat.ai/papers/10.1172/jci82826
The paper
Liao, H.-W., Hsu, J.-M., Xia, W., Wang, H.-L., Wang, Y.-N., Chang, W.-C., Arold, S. T., Chou, C.-K., Tsou, P.-H., Yamaguchi, H., Fang, Y.-F., Lee, H.-J., Lee, H.-H., Tai, S.-K., Yang, M.-H., Morelli, M. P., Sen, M., Ladbury, J. E., Chen, C.-H., . . . Hung, M.-C. (2015). PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response. Journal of Clinical Investigation. https://doi.org/10.1172/jci82826

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.